ThomasHHostetterMD
Nephrology • Cleveland, OHProfessor, Medicine, Case Western Reserve University School of Medicine
Are you Dr. Hostetter?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 60 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
11100 Euclid Ave
Cleveland, OH 44106Phone+1 216-844-8500
Summary
- Dr. Thomas Hostetter, MD is a nephrologist in Cleveland, Ohio. He is currently licensed to practice medicine in Ohio, North Carolina, and New York. He is affiliated with University of North Carolina Hospitals and is a Professor at Case Western Reserve University School of Medicine.
Education & Training
Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 1977 - 1978- Brigham and Women's HospitalResidency, Internal Medicine, 1975 - 1977
Baylor College of MedicineInternship, Internal Medicine, 1974 - 1975- Baylor College of MedicineClass of 1973
Certifications & Licensure
NC State Medical License 2019 - 2025
OH State Medical License 2011 - 2021
MN State Medical License 1982 - 2012
NY State Medical License 2006 - 2012
TX State Medical License 1974 - 1983
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1987
Clinical Trials
- Sodium Bicarbonate Supplementation in Chronic Kidney Disease Evaluation of Dose Response, Safety and Beneficial Effects Start of enrollment: 2009 Mar 01
- Alkali Therapy in Chronic Kidney Disease Start of enrollment: 2011 Oct 01
Publications & Presentations
PubMed
- 60 citationsEffects of Sodium Bicarbonate in CKD Stages 3 and 4: A Randomized, Placebo-Controlled, Multicenter Clinical Trial.Michal L. Melamed, Edward Horwitz, Mirela Dobre, Matthew K. Abramowitz, Liping Zhang
American Journal of Kidney Diseases. 2020-02-01 - 75 citationsCurrent Status of Bicarbonate in CKDMirela Dobre, Mahboob Rahman, Thomas H. Hostetter
Journal of the American Society of Nephrology. 2015-03-01 - 161 citationsCytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis developmentYi-An Ko, Davoud Mohtat, Masako Suzuki, Ae Seo Deok Park, María Concepción Izquierdo
Genome Biology. 2013-10-07
Press Mentions
Acidosis in Renal Disease: Should We Be Concerned?December 12th, 2020
Grant Support
- Alkali Therapy In Chronic Kidney DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2010
- Aliphatic Amines In UremiaNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2008
- Renal Adaptation And InjuryNational Institute Of Diabetes And Digestive And Kidney Diseases1987–1999
